- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01852552
Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement (CCQ)
Multicenter, prospective, observational study in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI) or high-risk patients undergoing aortic valve replacement (AVR).
The objectives of the study are:
- Description of neurocognitive status before and after transcatheter aortic valve implantation and aortic valve replacement procedures
- Description of Quality of Life (QoL) after these procedures
- Defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities
- Assessment of costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and costs of follow-up.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
In Italy, a nation-wide observational study endorsed by the Superior Institute of Health has been previously launched in order to evaluate appropriateness and effectiveness of aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) procedures: the OBservational Study of Effectiveness of AVR-TAVI procedures for severe Aortic steNosis Treatment (OBSERVANT). The present study was designed to complement the national survey on TAVI and AVR procedures including data about costs, cognitive functions and quality of life after these procedures. This integrated framework may help defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities and, on the other hand, should enable accurate evaluation of the impact of each kind of treatment on quality of life and neuropsychological functions. These elements could also represent relevant keys to decision-making to the different therapeutic strategies. In addition, we aim to ascertain costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and follow-up costs. Costs estimate, combined to the integrated physical and mental health status outcome for each treatment modality, may represent the background for subsequent cost-effectiveness analyses.
All consecutive patients undergoing transcatheter aortic valve implantation or aortic valve replacement (if age ≥ 80 years or Logistic Euroscore ≥ 15%) for aortic stenosis at participating centers during the period of enrollment will be included in the registry, after release of written informed consent. Allocation of patients to different treatment groups will be performed jointly by a cardiologist and a cardiac surgeon on the basis of a complete clinical framework, independently from the present study and in accordance with available guidelines. Type of treatment (for example, access site for TAVI, type of prosthesis…) will be decided by the physicians based on local clinical practice and general principles of good clinical practice.
The administration of neurocognitive and quality of life questionnaires will be performed before the procedure and after 3 months and 1 year by trained personnel following standard operation procedures defined by a coordinating unit. A telephone and web-based support for operators will be available throughout the entire duration of the study. A common methodology for data collection and analysis is defined to guarantee data reliability and homogeneity of assessments among the participating units. The cost analysis will be coordinated by the Regional Healthcare and Social Agency of the Emilia Romagna Region.
Data will be collected in a web-based database (OBSERVANT) through dedicated Case Records Forms and a final database will be built by merging this database with a separate database for costs and Hospital Discharge Records and Mortality Registry databases.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Bologna, Italia, 40138
- Institute of Cardiology, Azienda Ospedaliero-Universitaria di Bologna
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- All consecutive patients undergoing TAVI at participating centers during the period of enrollment
- All consecutive patients aged ≥80 years or with Logistic Euroscore ≥15% undergoing AVR at participating centers during the period of enrollment
Exclusion Criteria:
- Absence of informed consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: Coorte
- Prospettive temporali: Prospettiva
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Transcatheter aortic valve implantation
All consecutive patients undergoing TAVI at participating centres during study period
|
Patients undergoing TAVI with transfemoral, transapical, or any other vascular access
Altri nomi:
|
|
Aortic Valve Replacement
All consecutive patients aged ≥ 80 years or with Logistic Euroscore≥ 15% undergoing AVR for AS at participating centers during the period of enrollment
|
Surgical AVR, with all kind of commercially available prosthesis (stented, stentless, mechanical)
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mini Mental State Examination (MMSE)
Lasso di tempo: baseline, 3-month, 12-month
|
Changes in cognitive function after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
Hospital Anxiety and Depression Scale (HADS)
Lasso di tempo: baseline, 3-month, 12-month
|
Changes of emotional status after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Lasso di tempo: baseline, 3-month, 12-month
|
Changes in quality of life after transcatheter aortic valve implantation and surgical aortic valve replacement
|
baseline, 3-month, 12-month
|
|
In-hospital costs
Lasso di tempo: Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement
|
Calculation of precise hospital costs for transcatheter aortic valve implantation and surgical Aortic Valve Replacement, including costs of hospitalization, drugs and devices.
|
Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Myocardial infarction
Lasso di tempo: 30-day, 12-month and up to 2-year (longest available follow-up)
|
Incidence of myocardial infarction
|
30-day, 12-month and up to 2-year (longest available follow-up)
|
|
Stroke
Lasso di tempo: 30-day, 12-month and up to 2-year (longest available follow-up)
|
Incidence of stroke
|
30-day, 12-month and up to 2-year (longest available follow-up)
|
|
Pace-maker implantation
Lasso di tempo: 30-day, 12-month
|
Need for permanent pacing
|
30-day, 12-month
|
|
Vascular complications
Lasso di tempo: 30-day
|
Incidence of vascular complications as defined by the VARC
|
30-day
|
|
Bleedings
Lasso di tempo: 30-day
|
Incidence of bleedings as defined by the VARC
|
30-day
|
|
Acute kidney injury
Lasso di tempo: 30-day
|
Incidence of AKI as defined by the VARC
|
30-day
|
|
Follow-up costs
Lasso di tempo: 12-month
|
Evaluation of costs during follow-up, including new hospital admissions, outpatient clinic and drugs
|
12-month
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- GR-2009-1578270
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Stenosi della valvola aortica
-
National Heart, Lung, and Blood Institute (NHLBI)CompletatoNative e Valve in Valve Guasto della valvola aorticaStati Uniti
Prove cliniche su transcatheter aortic valve implantation
-
Institut für Pharmakologie und Präventive MedizinEdwards LifesciencesAttivo, non reclutanteMalattia cardiovascolareGermania, Austria, Olanda, Svizzera
-
NVT GmbHSospesoImpianto di valvola aortica transcatetereGermania, Spagna, Finlandia, Polonia, Svizzera
-
NVT GmbHCompletatoImpianto di valvola aortica transcatetereOlanda, Spagna, Germania